Stock PURE PURE BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials PURE Bioscience, Inc.

Equities

PURE

US74621T2096

Household Products

Market Closed - OTC Markets
Other stock markets
 12:24:58 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.071 USD +1.43% Intraday chart for PURE Bioscience, Inc. +5.97% -45.26%
Mar. 22 PURE Bioscience, Inc. announced that it has received $3 million in funding CI
Mar. 18 PURE Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 CI

Valuation

Fiscal Period: July 2018 2019 2020 2021 2022 2023
Capitalization 1 38.28 24.56 124.3 36.63 22.24 9.508
Enterprise Value (EV) 1 37.93 24.17 120.4 34.48 18.85 9.434
P/E ratio -5.07 x -3.61 x 30,426 x -14 x -5.08 x -2.39 x
Yield - - - - - -
Capitalization / Revenue 21.6 x 12.9 x 18 x 9.33 x 12 x 5.07 x
EV / Revenue 21.4 x 12.7 x 17.4 x 8.78 x 10.2 x 5.03 x
EV / EBITDA -5.79 x -4.52 x 614 x -16.1 x -5.87 x -2.69 x
EV / FCF -12.8 x -28.1 x 196 x -42.3 x -14.9 x -4.84 x
FCF Yield -7.81% -3.56% 0.51% -2.37% -6.72% -20.6%
Price to Book 29.9 x 21 x 25.9 x 11 x 5.69 x 35 x
Nbr of stocks (in thousands) 68,229 75,582 86,891 87,223 111,356 111,856
Reference price 2 0.5610 0.3250 1.430 0.4200 0.1997 0.0850
Announcement Date 10/25/18 10/30/19 10/8/20 10/28/21 10/28/22 10/30/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: July 2018 2019 2020 2021 2022 2023
Net sales 1 1.774 1.909 6.917 3.927 1.853 1.877
EBITDA 1 -6.554 -5.348 0.196 -2.139 -3.212 -3.511
EBIT 1 -6.839 -5.589 0.004 -2.311 -3.425 -3.628
Operating Margin -385.51% -292.77% 0.06% -58.85% -184.84% -193.29%
Earnings before Tax (EBT) 1 -7.442 -6.554 0.004 -2.319 -3.491 -3.961
Net income 1 -7.442 -6.554 0.004 -2.319 -3.491 -3.961
Net margin -419.5% -343.32% 0.06% -59.05% -188.4% -211.03%
EPS 2 -0.1106 -0.0899 0.000047 -0.0300 -0.0393 -0.0356
Free Cash Flow 1 -2.962 -0.8599 0.6144 -0.8159 -1.267 -1.947
FCF margin -166.99% -45.04% 8.88% -20.78% -68.4% -103.74%
FCF Conversion (EBITDA) - - 313.46% - - -
FCF Conversion (Net income) - - 15,359.38% - - -
Dividend per Share - - - - - -
Announcement Date 10/25/18 10/30/19 10/8/20 10/28/21 10/28/22 10/30/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: July 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.35 0.4 3.84 2.15 3.39 0.07
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -2.96 -0.86 0.61 -0.82 -1.27 -1.95
ROE (net income / shareholders' equity) -579% -530% 0.13% -56.9% -96.4% -189%
ROA (Net income/ Total Assets) -133% -155% 0.06% -27.2% -48.7% -71.9%
Assets 1 5.575 4.228 6.612 8.53 7.165 5.51
Book Value Per Share 2 0.0200 0.0200 0.0600 0.0400 0.0400 0
Cash Flow per Share 2 0.0100 0.0100 0.0400 0.0300 0.0300 0.0100
Capex 1 0.02 0.01 0.06 0.52 0.08 0.03
Capex / Sales 1.07% 0.37% 0.84% 13.27% 4.37% 1.76%
Announcement Date 10/25/18 10/30/19 10/8/20 10/28/21 10/28/22 10/30/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Household Products

1st Jan change Capi.
PURE BIOSCIENCE, INC. Stock PURE Bioscience, Inc.
-45.26% 7.94M
CHURCH & DWIGHT CO., INC. Stock Church & Dwight Co., Inc.
+12.44% 25.93B
THE CLOROX COMPANY Stock The Clorox Company
+2.73% 18.18B
PT UNILEVER INDONESIA TBK Stock PT Unilever Indonesia Tbk
-26.63% 6.09B
REYNOLDS CONSUMER PRODUCTS INC. Stock Reynolds Consumer Products Inc.
+6.04% 5.98B
WD-40 COMPANY Stock WD-40 Company
-5.67% 3.06B
LION CORPORATION Stock Lion Corporation
+5.20% 2.42B
JYOTHY LABS LIMITED Stock Jyothy Labs Limited
-12.14% 1.85B
SANO BRUNO'S ENTERPRISES LTD Stock Sano Bruno's Enterprises Ltd
+27.19% 936M
EARTH CORPORATION Stock Earth Corporation
-4.16% 618M
Other Household Products
  1. Stock Market
  2. Equities
  3. PURE Stock
  4. Financials PURE Bioscience, Inc.